Verus Capital Partners’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
CCM
EWM
Verus Capital Partners's AXGN Position: Q1 2020 in Review
Verus Capital Partners reduced its Axogen (AXGN) stake by 56% in Q1 2020, selling an estimated $31.8K and leaving 2,000 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #788.
Verus Capital Partners first reported a position in AXGN in Q4 2019 and has held it in 2 quarters since. The position peaked at $81K in Q4 2019. 116 funds tracked by Wall St. Rank hold AXGN as of Q1 2020.
- Verus Capital Partners held 2,000 shares of Axogen worth $21K as of Q1 2020.
- Verus Capital Partners sold 2,500 Axogen shares in Q1 2020, an estimated $31.8K.
- Axogen made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #788 holding.
- Verus Capital Partners first reported a position in Axogen in Q4 2019 and has held it in 2 quarters since.
- Verus Capital Partners's Axogen position peaked at $81K in Q4 2019.
- 116 funds tracked by Wall St. Rank held Axogen as of Q1 2020.
Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.